Centaur Pharmaceuticals
Mumbai, India· Est.
Fully integrated Indian pharma delivering APIs, formulations, and clinical services with a growing niche therapeutic pipeline.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
AI Company Overview
Fully integrated Indian pharma delivering APIs, formulations, and clinical services with a growing niche therapeutic pipeline.
PsychiatryRespiratoryDiabetes complicationsNephrology
Technology Platform
Integrated platform spanning API discovery and bulk manufacturing, GMP‑certified formulation of, and full‑service clinical research (LifeSan) with regulatory approvals across US, EU, and emerging markets.
Opportunities
Expansion of niche therapeutic pipeline (diabetic foot ulcer, CKD) and scaling contract research services for multinational sponsors present strong growth avenues.
Risk Factors
Regulatory scrutiny in multiple jurisdictions and reliance on a limited number of flagship products could affect revenue stability.
Competitive Landscape
Centaur competes with Indian generic manufacturers and contract research organizations; its integrated API‑to‑clinic model and unique NCEs differentiate it from pure‑play generics and CROs.